CXCL1 and systemic sclerosis: In addition, SSc patients with elevated serum CXCL1 levels showed an increased frequency of decreased % vital capacity, decreased % DLco, kidney involvement, presence of anti-topoisomerase I antibodies, and elevated serum IgG levels compared to patients with normal CXCL1 levels [16].